Actuate Therapeutics, Inc. – Filings and Transcripts

NASDAQ: ACTU
Share price (4/27/26): $2.85
Market cap (4/27/26): $67.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Draft registration statement

Ownership Filter

Voss Capital, LP

Schmitt Daniel M

Mazar Andrew Paul

Schmitt Daniel M

News Filter

Reports Positive Follow-Up Data From Its Randomized

Material Definitive Agreement, Financial Statements or Exhibits

Announces Proposed Public Offering of Common Stock

Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC